Australian Advisory Committee Recommends Changes For Psychiatric Drug Info; Sigma's Methadone Pulled Off Shelves For Relabeling
This article was originally published in The Pink Sheet Daily
A new medicinal safety AC will convene early in 2010 to consider recommendations for prescriber education and post-market surveillance of some psychiatric drugs.
You may also be interested in...
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.
Statistical analyses based on pivotal trial data and used to promote a drug must prove what they purport to prove, FDA's Office of Prescription Drug Promotion says in an NOV letter to Otsuka over a website for the leukemia drug Busulfex (busulfan).